TAC1 and neoplasm: One possible explanation is that ACE inhibition induces the accumulation of bradykinin (Wang et al., 2020) and substance P, (Liau et al., 2019), which have been identified as potential inducers of tumor proliferation (Muñoz and Coveñas, 2014).